Yakira Capital Management’s NRX Pharmaceuticals, Inc. Warrant NRXPW Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-15,409
| Closed | -$2K | – | 308 |
|
2023
Q4 | $2K | Sell |
15,409
-1,720
| -10% | -$223 | ﹤0.01% | 287 |
|
2023
Q3 | $1.37K | Hold |
17,129
| – | – | ﹤0.01% | 347 |
|
2023
Q2 | $4.28K | Hold |
17,129
| – | – | ﹤0.01% | 296 |
|
2023
Q1 | $3.08K | Hold |
17,129
| – | – | ﹤0.01% | 341 |
|
2022
Q4 | $4.28K | Hold |
17,129
| – | – | ﹤0.01% | 311 |
|
2022
Q3 | $5K | Hold |
17,129
| – | – | ﹤0.01% | 388 |
|
2022
Q2 | $2K | Hold |
17,129
| – | – | ﹤0.01% | 424 |
|
2022
Q1 | $15K | Sell |
17,129
-8,919
| -34% | -$7.81K | ﹤0.01% | 420 |
|
2021
Q4 | $48K | Sell |
26,048
-3,000
| -10% | -$5.53K | 0.01% | 362 |
|
2021
Q3 | $139K | Sell |
29,048
-11,652
| -29% | -$55.8K | 0.02% | 286 |
|
2021
Q2 | $145K | Hold |
40,700
| – | – | 0.02% | 282 |
|
2021
Q1 | $396K | Hold |
40,700
| – | – | 0.08% | 217 |
|
2020
Q4 | $191K | Sell |
40,700
-41,800
| -51% | -$196K | 0.05% | 207 |
|
2020
Q3 | $21K | Hold |
82,500
| – | – | 0.01% | 232 |
|
2020
Q2 | $37K | Hold |
82,500
| – | – | 0.02% | 145 |
|
2020
Q1 | $5K | Hold |
82,500
| – | – | ﹤0.01% | 151 |
|
2019
Q4 | $15K | Hold |
82,500
| – | – | ﹤0.01% | 147 |
|
2019
Q3 | $14K | Hold |
82,500
| – | – | ﹤0.01% | 145 |
|
2019
Q2 | $18K | Hold |
82,500
| – | – | ﹤0.01% | 138 |
|
2019
Q1 | $15K | Hold |
82,500
| – | – | ﹤0.01% | 121 |
|
2018
Q4 | $32K | Hold |
82,500
| – | – | 0.01% | 119 |
|
2018
Q3 | $34K | Hold |
82,500
| – | – | 0.01% | 131 |
|
2018
Q2 | $31K | Hold |
82,500
| – | – | 0.01% | 126 |
|
2018
Q1 | $31K | Hold |
82,500
| – | – | 0.01% | 123 |
|
2017
Q4 | $38K | Buy |
+82,500
| New | +$38K | 0.01% | 107 |
|